Olav M. Bakke
- Co-authors
- Ronald R. SchelineRolf K. BergeLouis LasagnaKenneth I. KaitinMichael ManocchiaFrancisco J. de AbajoWilliam M. WardellDonald S. Davies
- Topics
- Metabolism and Genetic Disorders (6 papers)Pharmacogenetics and Drug Metabolism (6 papers)Peroxisome Proliferator-Activated Receptors (5 papers)
- Partner nations
- NorwayUnited StatesUnited Kingdom
In The Last Decade
Olav M. Bakke
25 papers receiving 770 citations
Peers
Comparison fields: 5 of 93
- Molecular Biology 282
- Pharmacology 269
- Clinical Biochemistry 137
- Cancer Research 107
- Physiology 94
Countries citing papers authored by Olav M. Bakke
This map shows the geographic impact of Olav M. Bakke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olav M. Bakke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olav M. Bakke more than expected).
Fields of papers citing papers by Olav M. Bakke
This network shows the impact of papers produced by Olav M. Bakke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olav M. Bakke. The network helps show where Olav M. Bakke may publish in the future.
Co-authorship network of co-authors of Olav M. Bakke
This figure shows the co-authorship network connecting the top 25 collaborators of Olav M. Bakke. A scholar is included among the top collaborators of Olav M. Bakke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olav M. Bakke. Olav M. Bakke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | EL PLACEBO EN ENSAYOS CLINICOS CON MEDICAMENTOS | 3 |
| 2 | 151 | |
| 3 | 9 | |
| 4 | 69 | |
| 5 | 32 | |
| 6 | 27 | |
| 7 | 45 | |
| 8 | 15 | |
| 9 | 28 | |
| 10 | 1 | |
| 11 | 68 | |
| 12 | 21 | |
| 13 | 8 | |
| 14 | 17 | |
| 15 | 141 | |
| 16 | 20 | |
| 17 | 35 | |
| 18 | 17 | |
| 19 | 29 | |
| 20 | 35 |
About Olav M. Bakke
Olav M. Bakke is a scholar working on Pharmacology, Clinical Biochemistry and Biochemistry, having authored 25 papers that have together received 849 indexed citations. Recurring topics across this work include Metabolism and Genetic Disorders (6 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Peroxisome Proliferator-Activated Receptors (5 papers). The work is most often cited by research in Pharmacology (269 citations), Clinical Biochemistry (137 citations) and Toxicology (41 citations). Olav M. Bakke has collaborated with scholars based in Norway, United States and United Kingdom. Frequent co-authors include Ronald R. Scheline, Rolf K. Berge, Louis Lasagna, Kenneth I. Kaitin, Michael Manocchia, Francisco J. de Abajo, William M. Wardell, Donald S. Davies, Mikael Farstad and Asle Aarsland. Their work appears in journals such as Analytical Biochemistry, Journal of Nutrition and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.